Published in N Engl J Med on July 25, 1996
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Inflammation, atrophy, and gastric cancer. J Clin Invest (2007) 4.29
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest (2009) 3.26
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest (2001) 2.70
The epidemiology of gastric cancer. Gastric Cancer (2002) 2.58
The clinical relevance of strain types of Helicobacter pylori. Gut (1997) 1.99
Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg (2005) 1.96
Helicobacter pylori in the stomach--a paradox unmasked. N Engl J Med (1996) 1.85
Cellular and molecular aspects of gastric cancer. World J Gastroenterol (2006) 1.84
Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun (2004) 1.72
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut (2006) 1.67
Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol (2007) 1.57
Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol (2001) 1.51
Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol (2006) 1.48
Copy number variation in schizophrenia in Sweden. Mol Psychiatry (2014) 1.46
Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer. BMC Genomics (2009) 1.42
A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population. Nat Genet (2012) 1.37
Wild-type and interleukin-10-deficient regulatory T cells reduce effector T-cell-mediated gastroduodenitis in Rag2-/- mice, but only wild-type regulatory T cells suppress Helicobacter pylori gastritis. Infect Immun (2007) 1.31
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett (2010) 1.31
Multifactorial etiology of gastric cancer. Methods Mol Biol (2012) 1.29
Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett (2008) 1.29
Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Med (2009) 1.26
Fucosylation and gastrointestinal cancer. World J Hepatol (2010) 1.25
Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing. Gastroenterology (2010) 1.20
Natural history of Helicobacter pylori infection. Dig Liver Dis (2008) 1.20
Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect Immun (2009) 1.19
Gastric cancer: an infectious disease. Infect Dis Clin North Am (2010) 1.17
Antisense RNA modulation of alkyl hydroperoxide reductase levels in Helicobacter pylori correlates with organic peroxide toxicity but not infectivity. J Bacteriol (2007) 1.16
Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer (1998) 1.15
Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun (2009) 1.15
Relation between gastric cancer and previous peptic ulcer disease. Gut (1997) 1.14
The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut (1998) 1.13
Seroprevalence of Helicobacter pylori, incidence of gastric cancer, and peptic ulcer-associated hospitalizations in a Canadian Indian population. Dig Dis Sci (1999) 1.10
The effect of tobacco consumption and body mass index on complications and hospital stay after inguinal hernia surgery. Hernia (2006) 1.09
Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells. J Biol Chem (2008) 1.04
Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden. Clin Cancer Res (2012) 1.03
Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? Virchows Arch (2005) 1.02
Antiulcer drugs and gastric cancer. Dig Dis Sci (2005) 1.01
Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival. Gastrointest Endosc (2010) 1.00
Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D. Infect Immun (2005) 0.98
Detection of Helicobacter pylori in gastric mucosa of patients with gastroduodenal diseases by PCR-restriction analysis using the RNA polymerase gene (rpoB). J Clin Microbiol (2003) 0.96
Relationship of IL-1 and TNF-α polymorphisms with Helicobacter pylori in gastric diseases in a Brazilian population. Braz J Med Biol Res (2012) 0.96
Gastroenterostoma after Billroth antrectomy as a premalignant condition. World J Gastroenterol (2012) 0.94
Association between cag-pathogenicity island in Helicobacter pylori isolates from peptic ulcer, gastric carcinoma, and non-ulcer dyspepsia subjects with histological changes. World J Gastroenterol (2005) 0.94
Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut (2005) 0.91
Helicobacter pylori and gastric cancer: a state of the art review. Gastroenterol Hepatol Bed Bench (2015) 0.91
Higher frequency of secretor phenotype in O blood group - its benefits in prevention and/or treatment of some diseases. Int J Nanomedicine (2010) 0.90
Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ (2015) 0.89
Long-term proton pump inhibitor administration, H pylori and gastric cancer: lessons from the gerbil. Gut (2011) 0.88
Intestinal stem cell marker LGR5 expression during gastric carcinogenesis. World J Gastroenterol (2013) 0.88
The co-evolved Helicobacter pylori and gastric cancer: trinity of bacterial virulence, host susceptibility and lifestyle. Infect Agent Cancer (2007) 0.88
Factors that mediate colonization of the human stomach by Helicobacter pylori. World J Gastroenterol (2014) 0.86
Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. J Gastroenterol Hepatol (2014) 0.86
In vivo expression of Helicobacter pylori virulence genes in patients with gastritis, ulcer, and gastric cancer. Infect Immun (2011) 0.86
Helicobacter pylori infection induces duodenitis and superficial duodenal ulcer in Mongolian gerbils. Gut (2003) 0.85
A possible role of Helicobacter pylori infection in the etiology of chronic laryngitis. Eur Arch Otorhinolaryngol (1997) 0.85
Different risk factors influence peptic ulcer disease development in a Brazilian population. World J Gastroenterol (2012) 0.84
Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer. Korean J Intern Med (2013) 0.83
Risk assessment of gastric cancer caused by Helicobacter pylori using CagA sequence markers. PLoS One (2012) 0.83
Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.83
Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden. BMC Cancer (2014) 0.82
Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia. World J Gastroenterol (2010) 0.82
Probiotics against neoplastic transformation of gastric mucosa: effects on cell proliferation and polyamine metabolism. World J Gastroenterol (2014) 0.82
Helicobacter pylori, gastric ulcer, and duodenal ulcer. N Engl J Med (1996) 0.81
Vagotomy and Gastric Tumorigenesis. Curr Neuropharmacol (2016) 0.81
Role of Helicobacter pylori and p53 in regulation of gastric epithelial cell cycle phase progression. Dig Dis Sci (2002) 0.80
Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection. World J Gastroenterol (2015) 0.80
The usefulness of ulcer size and location in the differential diagnosis of benign and malignant gastric ulcer. Wien Klin Wochenschr (2013) 0.80
Long-term risk of gastrointestinal cancers in persons with gastric or duodenal ulcers. Cancer Med (2016) 0.79
Relation of atrophic gastritis with Helicobacter pylori-CagA(+) and interleukin-1 gene polymorphisms. World J Gastroenterol (2008) 0.79
Genomic fingerprinting and genotyping of Helicobacter pylori strains from patients with duodenal ulcer or gastric cancer from different geographic regions. Dig Dis Sci (2002) 0.79
A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States. Emerg Infect Dis (2000) 0.78
Effects of fucosylated milk of goat and mouse on Helicobacter pylori binding to Lewis b antigen. World J Gastroenterol (2004) 0.77
Genomic single nucleotide polymorphisms in the offspring of gastric cancer patients predispose to spasmolytic polypeptide-expressing metaplasia after H. pylori infection. J Biomed Sci (2015) 0.77
A comparison study of gastric cancer risk in patients with duodenal and gastric ulcer: roles of gastric mucosal histology and p53 codon 72 polymorphism. Dig Dis Sci (2004) 0.77
Helicobacter pylori, gastric ulcer, and duodenal ulcer. N Engl J Med (1996) 0.77
Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach. Dig Dis Sci (2014) 0.77
Helicobacter pylori Infection Induces Anemia, Depletes Serum Iron Storage, and Alters Local Iron-Related and Adult Brain Gene Expression in Male INS-GAS Mice. PLoS One (2015) 0.77
Helicobacter pylori virulence genes in the five largest islands of Indonesia. Gut Pathog (2015) 0.77
Comparison of mini-gastric bypass with sleeve gastrectomy in a mainly super-obese patient group: first results. Surg Endosc (2016) 0.76
Effects of the Ethyl Acetate Fraction of Alchornea triplinervia on Healing Gastric Ulcer in Rats. Pharmaceuticals (Basel) (2011) 0.76
Helicobacter pylori in gastric corpus of patients 20 years after partial gastric resection. World J Gastroenterol (2004) 0.76
Antidepressants and Gastric Cancer: A Nationwide Population-Based Nested Case-Control Study. PLoS One (2015) 0.76
Gastrin and Gastric Cancer. Front Endocrinol (Lausanne) (2017) 0.76
Risk Factors for Metachronous Recurrence after Endoscopic Submucosal Dissection of Early Gastric Cancer. J Korean Med Sci (2017) 0.75
ANTI-ULCEROGENIC EFFICACY AND MECHANISMS OF EDIBLE AND NATURAL INGREDIENTS IN NSAID-INDUCED ANIMAL MODELS. Afr J Tradit Complement Altern Med (2017) 0.75
Dietary factors modulate Helicobacter-associated gastric cancer in rodent models. Toxicol Pathol (2013) 0.75
Risk factors for intestinal metaplasia in concomitant gastric and duodenal ulcer disease. Exp Ther Med (2014) 0.75
Helicobacter pylori infection and low dietary iron alter behavior, induce iron deficiency anemia, and modulate hippocampal gene expression in female C57BL/6 mice. PLoS One (2017) 0.75
VacA and CagA Status as Biomarker of Two Opposite End Outcomes of Helicobacter pylori Infection (Gastric Cancer and Duodenal Ulcer) in a Moroccan Population. PLoS One (2017) 0.75
The discrepancy between genetic polymorphism of p53 codon 72 and the expression of p53 protein in Helicobacter pylori-associated gastric cancer in Korea. Dig Dis Sci (2009) 0.75
Alteration of sister chromatid exchange frequencies in gastric cancer and chronic atrophic gastritis patients with and without H. pylori infection. World J Gastroenterol (2008) 0.75
Family history is an independent risk factor for the progression of gastric atrophy among patients with Helicobacter pylori infection. United European Gastroenterol J (2016) 0.75
Helicobacter pylori and gastric acid: an intimate and reciprocal relationship. Therap Adv Gastroenterol (2016) 0.75
Combination of Triple Therapy and Chronic PPI Use May Decrease Risk of Colonic Adenomatous Polyps in Helicobacter pylori Infection. Gastroenterol Res Pract (2015) 0.75
Association Between Colorectal Cancer and Atherosclerotic Diseases: A Study Using a National Inpatient Database in Japan. Dig Dis Sci (2016) 0.75
The Role of Stem Cells in the Treatment of Cerebral Palsy: a Review. Mol Neurobiol (2016) 0.75
Enigmas, priorities and opportunities in cancer epidemiology. Eur J Epidemiol (2017) 0.75
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30
Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Effect of adenosine on atrioventricular (AV) conduction. Pacing Clin Electrophysiol (1990) 5.83
Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med (1998) 5.66
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96
Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology (1995) 3.86
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79
The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77
Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63
Stressful life events and Graves' disease. Lancet (1991) 3.63
Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst (1997) 3.57
Should the mission of epidemiology include the eradication of poverty? Lancet (1998) 3.42
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37
Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology (2001) 3.17
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.69
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.65
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet (1990) 2.58
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control (1997) 2.52
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology (1991) 2.51
Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51
Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50
International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50
Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49